Table of Contents Author Guidelines Submit a Manuscript
International Journal of Medicinal Chemistry
Volume 2012, Article ID 412614, 6 pages
http://dx.doi.org/10.1155/2012/412614
Research Article

Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors

1Department of Medicinal Chemistry, MethylGene Inc., 7150 Rue Frederick-Banting, Suite 200, Montréal, QC, Canada H4S 2A1
2Department of Cell Biology and Pharmacology, MethylGene Inc., 7150 Rue Frederick-Banting, Suite 200, Montréal, QC, Canada H4S 2A1
3Department of PK/Analytical Chemistry, MethylGene Inc., 7150 Rue Frederick-Banting, Suite 200, Montréal, QC, Canada H4S 2A1

Received 5 December 2011; Revised 13 February 2012; Accepted 13 February 2012

Academic Editor: O. Bruno

Copyright © 2012 Stéphane L. Raeppel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [1 citation]

The following is the list of published articles that have cited the current article.

  • Zhigang Xu, Andrew Ambrose, Hong-yu Li, Brendan Frett, Nick McConnell, and Yuanxiang Wang, “Identification of pyrazine-based TrkA inhibitors: design, synthesis, evaluation, and computational modeling studies,” Med. Chem. Commun., vol. 5, no. 10, pp. 1507–1514, 2014. View at Publisher · View at Google Scholar